Mucin1 and Mucin16: Therapeutic Targets for Cancer Therapy

被引：58

作者：

Lee, Dong-Hee ^{[1
]}

Choi, Seunghyun ^{[2
]}

Park, Yoon ^{[2
]}

Jin, Hyung-seung ^{[1
]}

机构：

[1] Univ Ulsan, Asan Med Ctr, Asan Inst Life Sci, Dept Convergence Med,Coll Med, Seoul 05505, South Korea

[2] Korea Inst Sci & Technol KIST, Biomed Res Inst, Ctr Theragnosis, Seoul 02792, South Korea

来源：

PHARMACEUTICALS | 2021年 / 14卷 / 10期

基金：

新加坡国家研究基金会;

关键词：

mucin; MUC1; MUC16; immunotherapy; cancer vaccine; CAR (chimeric antigen receptor); ADC (antibody-drug conjugate); EPITHELIAL OVARIAN-CANCER; GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; CARCINOMA-ASSOCIATED ANTIGEN; MUC1; ONCOPROTEIN; MONOCLONAL-ANTIBODY; TUMOR-MARKER; CA; 125; IMMUNOLOGICAL RESPONSE; MAINTENANCE THERAPY;

D O I：

10.3390/ph14101053

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The mucin (MUC) family is a group of highly glycosylated macromolecules that are abundantly expressed in mammalian epithelial cells. MUC proteins contribute to the formation of the mucus barrier and thus have protective functions against infection. Interestingly, some MUC proteins are aberrantly expressed in cancer cells and are involved in cancer development and progression, including cell growth, proliferation, the inhibition of apoptosis, chemoresistance, metabolic reprogramming, and immune evasion. With their unique biological and structural features, MUC proteins have been considered promising therapeutic targets and also biomarkers for human cancer. In this review, we discuss the biological roles of the transmembrane mucins MUC1 and MUC16 in the context of hallmarks of cancer and current efforts to develop MUC1- and MUC16-targeted therapies.</p>

引用

页数：26

共 171 条

[1] MUC1 oncoprotein blocks death receptor-mediated apoptosis by inhibiting recruitment of caspase-8 [J].

Agata, Naoki ;

Ahmad, Rehan ;

Kawano, Takeshi ;

Raina, Deepak ;

Kharbanda, Surender ;

Kufe, Donald .

CANCER RESEARCH, 2008, 68 (15) :6136-6144

[2] Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2 [J].

Agrawal, B ;

Krantz, MJ ;

Reddish, MA ;

Longenecker, BM .

NATURE MEDICINE, 1998, 4 (01) :43-49

[3] MUC1 oncoprotein activates the IκB kinase β complex and constitutive NF-κB signalling [J].

Ahmad, Rehan ;

Raina, Deepak ;

Trivedi, Vishal ;

Ren, Jian ;

Rajabi, Hasan ;

Kharbanda, Surender ;

Kufe, Donald .

NATURE CELL BIOLOGY, 2007, 9 (12) :1419-U146

[4] Targeting MUC1-C inhibits the AKT-S6K1-eIF4A pathway regulating TIGAR translation in colorectal cancer [J].

Ahmad, Rehan ;

Alam, Maroof ;

Hasegawa, Masanori ;

Uchida, Yasumitsu ;

Al-Obaid, Omar ;

Kharbanda, Surender ;

Kufe, Donald .

MOLECULAR CANCER, 2017, 16

[5] CA125/MUC16 interacts with Src family kinases, and over-expression of its C-terminal fragment in human epithelial cancer cells reduces cell-cell adhesion [J].

Akita, Kaoru ;

Tanaka, Minarni ;

Tanida, Shuhei ;

Mori, Yugo ;

Toda, Munetoyo ;

Nakada, Hiroshi .

EUROPEAN JOURNAL OF CELL BIOLOGY, 2013, 92 (8-9) :257-263

[6] Muc1 affects c-Src signaling in PyV MT-induced mammary tumorigenesis [J].

Al Masri, A ;

Gendler, SJ .

ONCOGENE, 2005, 24 (38) :5799-5808

[7]

Andrianifahanana M, 2001, CLIN CANCER RES, V7, P4033

[8] CELLULAR MUCINS - TARGETS FOR IMMUNOTHERAPY [J].

APOSTOLOPOULOS, V ;

MCKENZIE, IFC .

CRITICAL REVIEWS IN IMMUNOLOGY, 1994, 14 (3-4) :293-309

[9] xCell: digitally portraying the tissue cellular heterogeneity landscape [J].

Aran, Dvir ;

Hu, Zicheng ;

Butte, Atul J. .

GENOME BIOLOGY, 2017, 18

[10] MUC16 mucin is expressed by the human ocular surface epithelia and carries the H185 carbohydrate epitope [J].

Argüeso, P ;

Spurr-Michaud, S ;

Russo, CL ;

Tisdale, A ;

Gipson, IK .

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (06) :2487-2495

← 1 2 3 4 5 6 7 8 9 10 →